Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

ClpB mutants of Francisella tularensis subspecies holarctica and tularensis are defective for type VI secretion and intracellular replication.

Alam A, Golovliov I, Javed E, Sjöstedt A.

Sci Rep. 2018 Jul 27;8(1):11324. doi: 10.1038/s41598-018-29745-4.

2.

Vaccine-Mediated Mechanisms Controlling Replication of Francisella tularensis in Human Peripheral Blood Mononuclear Cells Using a Co-culture System.

Eneslätt K, Golovliov I, Rydén P, Sjöstedt A.

Front Cell Infect Microbiol. 2018 Feb 7;8:27. doi: 10.3389/fcimb.2018.00027. eCollection 2018.

3.

IFN-γ extends the immune functions of Guanylate Binding Proteins to inflammasome-independent antibacterial activities during Francisella novicida infection.

Wallet P, Benaoudia S, Mosnier A, Lagrange B, Martin A, Lindgren H, Golovliov I, Michal F, Basso P, Djebali S, Provost A, Allatif O, Meunier E, Broz P, Yamamoto M, Py BF, Faudry E, Sjöstedt A, Henry T.

PLoS Pathog. 2017 Oct 2;13(10):e1006630. doi: 10.1371/journal.ppat.1006630. eCollection 2017 Oct.

4.

An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy.

Golovliov I, Lindgren H, Eneslätt K, Conlan W, Mosnier A, Henry T, Sjöstedt A.

Front Cell Infect Microbiol. 2016 Nov 25;6:152. eCollection 2016.

5.

Clonality of erythromycin resistance in Francisella tularensis.

Karlsson E, Golovliov I, Lärkeryd A, Granberg M, Larsson E, Öhrman C, Niemcewicz M, Birdsell D, Wagner DM, Forsman M, Johansson A.

J Antimicrob Chemother. 2016 Oct;71(10):2815-23. doi: 10.1093/jac/dkw235. Epub 2016 Jun 21.

PMID:
27334667
6.

Mechanisms of heme utilization by Francisella tularensis.

Lindgren H, Lindgren L, Golovliov I, Sjöstedt A.

PLoS One. 2015 Mar 10;10(3):e0119143. doi: 10.1371/journal.pone.0119143. eCollection 2015.

7.

Identification of mechanisms for attenuation of the FSC043 mutant of Francisella tularensis SCHU S4.

Lindgren M, Tancred L, Golovliov I, Conlan W, Twine SM, Sjöstedt A.

Infect Immun. 2014 Sep;82(9):3622-35. doi: 10.1128/IAI.01406-13. Epub 2014 Jun 16.

8.

A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.

Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W.

PLoS One. 2013 Nov 13;8(11):e78671. doi: 10.1371/journal.pone.0078671. eCollection 2013.

9.

The Francisella tularensis LVS ΔpdpC mutant exhibits a unique phenotype during intracellular infection.

Lindgren M, Bröms JE, Meyer L, Golovliov I, Sjöstedt A.

BMC Microbiol. 2013 Jan 29;13:20. doi: 10.1186/1471-2180-13-20.

10.

Administration of a nitric oxide donor inhibits mglA expression by intracellular Francisella tularensis and counteracts phagosomal escape and subversion of TNF-α secretion.

Tancred L, Telepnev MV, Golovliov I, Andersson B, Andersson H, Lindgren H, Sjöstedt A.

J Med Microbiol. 2011 Nov;60(Pt 11):1570-83. doi: 10.1099/jmm.0.032870-0. Epub 2011 Jun 23.

PMID:
21700740
11.

The type IV pilin, PilA, is required for full virulence of Francisella tularensis subspecies tularensis.

Forslund AL, Salomonsson EN, Golovliov I, Kuoppa K, Michell S, Titball R, Oyston P, Noppa L, Sjöstedt A, Forsberg A.

BMC Microbiol. 2010 Aug 26;10:227. doi: 10.1186/1471-2180-10-227.

12.

Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.

Conlan JW, Shen H, Golovliov I, Zingmark C, Oyston PC, Chen W, House RV, Sjöstedt A.

Vaccine. 2010 Feb 17;28(7):1824-31. doi: 10.1016/j.vaccine.2009.12.001. Epub 2009 Dec 16.

13.

Reintroduction of two deleted virulence loci restores full virulence to the live vaccine strain of Francisella tularensis.

Salomonsson E, Kuoppa K, Forslund AL, Zingmark C, Golovliov I, Sjöstedt A, Noppa L, Forsberg A.

Infect Immun. 2009 Aug;77(8):3424-31. doi: 10.1128/IAI.00196-09. Epub 2009 Jun 8.

14.

Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model.

Kadzhaev K, Zingmark C, Golovliov I, Bolanowski M, Shen H, Conlan W, Sjöstedt A.

PLoS One. 2009;4(5):e5463. doi: 10.1371/journal.pone.0005463. Epub 2009 May 8.

15.

Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro.

Hazlett KR, Caldon SD, McArthur DG, Cirillo KA, Kirimanjeswara GS, Magguilli ML, Malik M, Shah A, Broderick S, Golovliov I, Metzger DW, Rajan K, Sellati TJ, Loegering DJ.

Infect Immun. 2008 Oct;76(10):4479-88. doi: 10.1128/IAI.00610-08. Epub 2008 Jul 21.

16.

MglA and Igl proteins contribute to the modulation of Francisella tularensis live vaccine strain-containing phagosomes in murine macrophages.

Bönquist L, Lindgren H, Golovliov I, Guina T, Sjöstedt A.

Infect Immun. 2008 Aug;76(8):3502-10. doi: 10.1128/IAI.00226-08. Epub 2008 May 12.

17.

The heat-shock protein ClpB of Francisella tularensis is involved in stress tolerance and is required for multiplication in target organs of infected mice.

Meibom KL, Dubail I, Dupuis M, Barel M, Lenco J, Stulik J, Golovliov I, Sjöstedt A, Charbit A.

Mol Microbiol. 2008 Mar;67(6):1384-401. doi: 10.1111/j.1365-2958.2008.06139.x. Epub 2008 Feb 15.

18.

Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species with special reference to the role of KatG.

Lindgren H, Shen H, Zingmark C, Golovliov I, Conlan W, Sjöstedt A.

Infect Immun. 2007 Mar;75(3):1303-9. Epub 2007 Jan 8.

19.

A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.

Twine S, Byström M, Chen W, Forsman M, Golovliov I, Johansson A, Kelly J, Lindgren H, Svensson K, Zingmark C, Conlan W, Sjöstedt A.

Infect Immun. 2005 Dec;73(12):8345-52.

21.
22.

Factors affecting the escape of Francisella tularensis from the phagolysosome.

Lindgren H, Golovliov I, Baranov V, Ernst RK, Telepnev M, Sjöstedt A.

J Med Microbiol. 2004 Oct;53(Pt 10):953-8.

PMID:
15358816
23.

An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells.

Golovliov I, Baranov V, Krocova Z, Kovarova H, Sjöstedt A.

Infect Immun. 2003 Oct;71(10):5940-50.

24.

A method for allelic replacement in Francisella tularensis.

Golovliov I, Sjöstedt A, Mokrievich A, Pavlov V.

FEMS Microbiol Lett. 2003 May 28;222(2):273-80.

25.
26.

Survival and growth of Francisella tularensis in Acanthamoeba castellanii.

Abd H, Johansson T, Golovliov I, Sandström G, Forsman M.

Appl Environ Microbiol. 2003 Jan;69(1):600-6.

27.
28.

Genetic organization of the Francisella plasmid pFNL10.

Pomerantsev AP, Golovliov IR, Ohara Y, Mokrievich AN, Obuchi M, Norqvist A, Kuoppa K, Pavlov VM.

Plasmid. 2001 Nov;46(3):210-22.

PMID:
11735370
30.
32.

Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis.

Golovliov I, Kuoppa K, Sjöstedt A, Tärnvik A, Sandström G.

FEMS Immunol Med Microbiol. 1996 Mar;13(3):239-44.

PMID:
8861036
33.

Outer membranes of a lipopolysaccharide-protein complex (LPS-17 kDa protein) as chemical tularemia vaccines.

Khlebnikov VS, Golovliov IR, Kulevatsky DP, Tokhtamysheva NV, Averin SF, Zhemchugov VE, Pchelintsev SY, Afanasiev SS, Shcherbakov GY.

FEMS Immunol Med Microbiol. 1996 Mar;13(3):227-33.

PMID:
8861034
34.

Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism.

Tärnvik A, Ericsson M, Golovliov I, Sandström G, Sjöstedt A.

FEMS Immunol Med Microbiol. 1996 Mar;13(3):221-5.

PMID:
8861033
35.

Cytokine expression in the liver during the early phase of murine tularemia.

Golovliov I, Sandström G, Ericsson M, Sjöstedt A, Tärnvik A.

Infect Immun. 1995 Feb;63(2):534-8.

36.

Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis.

Golovliov I, Ericsson M, Akerblom L, Sandström G, Tärnvik A, Sjöstedt A.

Vaccine. 1995 Feb;13(3):261-7.

PMID:
7631511

Supplemental Content

Loading ...
Support Center